Thomas Möller

12.9k total citations · 4 hit papers
100 papers, 8.9k citations indexed

About

Thomas Möller is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas Möller has authored 100 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 25 papers in Molecular Biology and 23 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas Möller's work include Neuroinflammation and Neurodegeneration Mechanisms (44 papers), Immune cells in cancer (14 papers) and Neuroscience and Neuropharmacology Research (12 papers). Thomas Möller is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (44 papers), Immune cells in cancer (14 papers) and Neuroscience and Neuropharmacology Research (12 papers). Thomas Möller collaborates with scholars based in United States, Germany and United Kingdom. Thomas Möller's co-authors include Helmut Kettenmann, Gwenn A. Garden, Patrick Weydt, Jonathan R. Weinstein, Bruce R. Ransom, Erik Boddeke, Anke Witting, Nephi Stella, Bart J. L. Eggen and Soyon Hong and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas Möller

97 papers receiving 8.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Major Risk Factors for Alzheimer’s Disease: Age, Sex, and Genes Modulate the Microglia Response to Aβ Plaques

2019 539 citations Thomas Möller et al. profile →
Transcriptomic analysis of purified human cortical microglia reveals age-associated changes

2017 510 citations Inge R. Holtman, Thomas Möller et al. profile →
Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis

2015 437 citations Inge R. Holtman, Paul D. Wes et al. profile →
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

2021 207 citations Thomas Möller, Bart J. L. Eggen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Thomas Möller	4.0k	2.9k	2.0k	1.9k	1.5k	100	8.9k
Akio Suzumura	5.7k 1.4×	3.4k 1.2×	2.3k 1.2×	3.6k 1.9×	2.0k 1.3×	192	11.9k
Knut Biber	4.9k 1.2×	1.6k 0.6×	1.6k 0.8×	2.5k 1.3×	1.4k 0.9×	96	8.5k
Eng‐Ang Ling	4.2k 1.1×	3.3k 1.1×	2.5k 1.3×	1.5k 0.8×	1.4k 0.9×	263	11.0k
Mami Noda	3.0k 0.8×	2.0k 0.7×	1.7k 0.9×	1.2k 0.6×	1.2k 0.8×	124	6.9k
Cristina Limatola	2.9k 0.7×	2.4k 0.8×	1.7k 0.8×	1.5k 0.8×	875 0.6×	180	7.3k
Richard M. Ransohoff	4.1k 1.0×	2.0k 0.7×	1.3k 0.6×	3.0k 1.5×	1.7k 1.1×	60	8.7k
Susanne A. Wolf	2.9k 0.7×	3.0k 1.1×	1.2k 0.6×	2.0k 1.0×	1.1k 0.7×	97	8.5k
G. W. Kreutzberg	4.3k 1.1×	1.8k 0.6×	2.4k 1.2×	1.7k 0.9×	1.3k 0.8×	47	7.2k
Dana Giulian	5.0k 1.3×	2.5k 0.9×	2.5k 1.3×	2.1k 1.1×	1.7k 1.1×	51	8.9k
Elly M. Hol	4.6k 1.1×	5.8k 2.0×	2.8k 1.4×	1.8k 0.9×	3.4k 2.3×	198	13.4k

Countries citing papers authored by Thomas Möller

Since Specialization

Citations

This map shows the geographic impact of Thomas Möller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Möller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Möller more than expected).

Fields of papers citing papers by Thomas Möller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Möller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Möller. The network helps show where Thomas Möller may publish in the future.

Co-authorship network of co-authors of Thomas Möller

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Möller. A scholar is included among the top collaborators of Thomas Möller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Möller. Thomas Möller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Staal, Roland G. W., Adarsh Gandhi, Manuel Cajina, et al.. (2022). Inhibition of P2X7 receptors by Lu AF27139 diminishes colonic hypersensitivity and CNS prostanoid levels in a rat model of visceral pain. Purinergic Signalling. 18(4). 499–514. 2 indexed citations

Staal, Roland G. W., Tanzilya Khayrullina, Hong Zhang, et al.. (2016). Inhibition of the potassium channel K Ca 3.1 by senicapoc reverses tactile allodynia in rats with peripheral nerve injury. European Journal of Pharmacology. 795. 1–7. 27 indexed citations

Dale, Elena, Roland G. W. Staal, Claudia Eder, & Thomas Möller. (2016). K_Ca3.1—a microglial target ready for drug repurposing?. Glia. 64(10). 1733–1741. 28 indexed citations

Emde, Anna, Chen Eitan, Iddo Magen, et al.. (2015). Dysregulated mi RNA biogenesis downstream of cellular stress and ALS ‐causing mutations: a new mechanism for ALS. The EMBO Journal. 34(21). 2633–2651. 154 indexed citations

Wes, Paul D., Inge R. Holtman, Erik Boddeke, Thomas Möller, & Bart J. L. Eggen. (2015). Next generation transcriptomics and genomics elucidate biological complexity of microglia in health and disease. Glia. 64(2). 197–213. 109 indexed citations

Biber, Knut, Thomas Möller, Erik Boddeke, & Marco Prinz. (2015). Central nervous system myeloid cells as drug targets: current status and translational challenges. Nature Reviews Drug Discovery. 15(2). 110–124. 94 indexed citations

Hu, Ruozhen, Dominique Kagele, Thomas B. Huffaker, et al.. (2014). miR-155 Promotes T Follicular Helper Cell Accumulation during Chronic, Low-Grade Inflammation. Immunity. 41(4). 605–619. 124 indexed citations

Kwan, Wanda, Anna Magnusson, Austin Chou, et al.. (2012). Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease. Journal of Neuroscience. 32(1). 133–142. 60 indexed citations

Kwan, Wanda, Ulrike Träger, Dimitrios Davalos, et al.. (2012). Mutant huntingtin impairs immune cell migration in Huntington disease. Journal of Clinical Investigation. 122(12). 4737–4747. 114 indexed citations

10.

Sexton, Michelle, Grace Woodruff, Eiron Cudaback, et al.. (2009). Binding of NIR-conPK and NIR-6T to Astrocytomas and Microglial Cells: Evidence for a Protein Related to TSPO. PLoS ONE. 4(12). e8271–e8271. 8 indexed citations

11.

Weinstein, Jonathan R., Matthew Zhang, Mansur A. Kutlubaev, et al.. (2008). Thrombin-Induced Regulation of CD95(Fas) Expression in the N9 Microglial Cell Line: Evidence for Involvement of Proteinase-Activated Receptor1 and Extracellular Signal-Regulated Kinase 1/2. Neurochemical Research. 34(3). 445–452. 14 indexed citations

12.

Giorgini, Flaviano, Thomas Möller, Wanda Kwan, et al.. (2007). Histone Deacetylase Inhibition Modulates Kynurenine Pathway Activation in Yeast, Microglia, and Mice Expressing a Mutant Huntingtin Fragment. Journal of Biological Chemistry. 283(12). 7390–7400. 80 indexed citations

13.

Kjeldsen, Anette Drøhse, Thomas Möller, Klaus Brusgaard, P. Vase, & Poul Erik Andersen. (2005). Clinical symptoms according to genotype amongst patients with hereditary haemorrhagic telangiectasia. Journal of Internal Medicine. 258(4). 349–355. 73 indexed citations

14.

Gahbauer, R., T. Landberg, J. Chavaudra, et al.. (2004). 3 Physical Characteristics of Electron Beams. Journal of the ICRU. 4(1). 39–48. 1 indexed citations

15.

Gahbauer, R., T. Landberg, J. Chavaudra, et al.. (2004). Prescribing, Recording, and Reporting Electron Beam Therapy. Journal of the ICRU. 4(1). 1–2. 3 indexed citations

16.

Gahbauer, R., T. Landberg, J. Chavaudra, et al.. (2004). References. Journal of the ICRU. 4(1). 95–100. 1 indexed citations

17.

Gahbauer, R., T. Landberg, J. Chavaudra, et al.. (2004). Prescribing, Recording, and Reporting Electron Beam Therapy. Journal of the ICRU. 4(1). 5–9. 3 indexed citations

18.

Möller, Thomas, David B. Musante, & Bruce R. Ransom. (1999). Lysophosphatidic acid-induced calcium signals in cultured rat oligodendrocytes. Neuroreport. 10(14). 2929–2932. 31 indexed citations

19.

Müller, Thomas, Thomas Möller, Thomas Berger, J. Schnitzer, & Helmut Kettenmann. (1992). Calcium Entry Through Kainate Receptors and Resulting Potassium-Channel Blockade in Bergmann Glial Cells. Science. 256(5063). 1563–1566. 290 indexed citations

20.

Geisler, Carsten, Jan Dominik Kuhlmann, Thomas Möller, Torben Plesner, & Bent Rubin. (1990). Transmembrane Signalling via HLA‐DR Molecules on T Cells from a Sezary T‐Cell Leukaemia Line. Scandinavian Journal of Immunology. 32(6). 731–735. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact